Sanofi ADS (SNY) News Nov 18, 2014, 10:20 a.m. MarketWatch

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Sanofi ADS (SNY) News Nov 18, 2014, 10:20 a.m.
MarketWatch News on SNY
If you're looking big pharma, look no further than Actavis 11:34 a.m. Nov. 17, 2014 - The Trading Deck
Medical-bill mess is worse than you thought 5:00 a.m. Nov. 12, 2014 - Richard Eisenberg
Sanofi slumps, Fiat Chrysler rallies: Europe’s big stock movers 12:22 p.m. Oct. 29, 2014 - Sara Sjolin
Sanofi board ousts CEO Viehbacher after clash over strategy 4:25 a.m. Oct. 29, 2014 - William Horobin
Sanofi shares fall 4% after CEO resigns 3:14 a.m. Oct. 29, 2014 - Sara Sjolin
Novartis advances; Sanofi slumps: Europe’s big stock movers 11:59 a.m. Oct. 28, 2014 - Sara Sjolin
Sanofi's profit drops slightly on revamp costs 1:59 a.m. Oct. 28, 2014 - MarketWatch.com
RBS, Lloyds climb; Sanofi slips: Europe’s big stock moves 10:56 a.m. Sept. 11, 2014 - Sara Sjolin
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
U.S. small caps lead broad stock-market gains 3:09 p.m. Aug. 11, 2014 - Anora Mahmudova
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
MannKind shares soar on Sanofi deal; investors ignore earnings report 9:10 a.m. Aug. 11, 2014 - Russ Britt
MannKind shares soar 23% on Sanofi deal over Afrezza 6:04 a.m. Aug. 11, 2014 - Silvia Ascarelli
Sanofi, MannKind to commercialize Afrezza insulin therapy 4:32 a.m. Aug. 11, 2014 - Silvia Ascarelli
Zoetis narrows full-year earnings guidance 7:12 a.m. Aug. 5, 2014 - MarketWatch.com
Sanofi profit jumps 73%; earnings outlook lifted 2:22 a.m. July 31, 2014 - MarketWatch.com
Regeneron shares jump after cholesterol drug meets test goals 10:16 a.m. July 30, 2014 - Russ Britt
Maybe Amazon will unveil a toaster today 7:08 a.m. June 18, 2014 - Marek Fuchs
Merck, Sanofi, Glaxo explore shedding older drugs 4:43 p.m. June 3, 2014 - MarketWatch.com
Loading more headlines...
Advertisement
Other News on SNY
Sanofi: Recent Plunge Is A Buying Opportunity 9:00 a.m. Today - Seeking Alpha
Companies Spending the Most on R&D 8:39 a.m. Today - 247WallSt.com
Amicus Therapeutics' Fabry disease drug candidate improves cardiac health marker 7:31 a.m. Nov. 17, 2014 - Seeking Alpha
CVRs on Lemtrada +135% following approval 7:19 a.m. Nov. 17, 2014 - Seeking Alpha
Amicus Drug Improves Marker of Heart Health in Fabry Patients 10:01 a.m. Nov. 15, 2014 - TheStreet.com
Genzyme's Lemtrada approved by the FDA 9:47 p.m. Nov. 14, 2014 - Seeking Alpha
Significant Changes In Buffett and Berkshire Hathaway Holdings 4:18 p.m. Nov. 14, 2014 - 247WallSt.com
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences 9:23 a.m. Nov. 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – CMN PODD ALGN SNY 12:30 p.m. Nov. 11, 2014 - InvestorPlace.com
Actavis Says 'Let's Make A Deal' 9:42 a.m. Nov. 11, 2014 - Seeking Alpha
Sanofi/Regeneron asthma drug successful in Phase 2 trial 7:44 a.m. Nov. 11, 2014 - Seeking Alpha
MannKind Is On The Mend 7:07 p.m. Nov. 7, 2014 - Seeking Alpha
Alnylam Pharmaceuticals Staying Ridiculously Busy 11:25 a.m. Nov. 7, 2014 - Seeking Alpha
Today's Market: Earnings And News Moving These 5 Stocks 10:01 a.m. Nov. 6, 2014 - Seeking Alpha
Regeneron Plunges In What Barron's Calls A Significant Disappointment: My Analysis 8:32 a.m. Nov. 6, 2014 - Seeking Alpha
6 Dividend-Paying Stocks From Around the World 10:34 a.m. Nov. 5, 2014 - Barrons.com
MannKind’s Progress Seen More Gradual 10:25 a.m. Nov. 5, 2014 - Barrons.com
What We Learned From The MannKind 3rd Quarter Conference Call 8:27 a.m. Nov. 5, 2014 - Seeking Alpha
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership 1:40 p.m. Nov. 4, 2014 - TheStreet.com
MannKind Corporation Stock: MNKD Third-Quarter Earnings Takeaways 6:23 a.m. Nov. 4, 2014 - InvestorPlace.com
Loading more headlines...
Press Releases on SNY
Genzyme’s Lemtrada Approved by the FDA 9:00 p.m. Nov. 14, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma 1:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis 6:00 a.m. Nov. 4, 2014 - BusinessWire - BZX
Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older 8:30 a.m. Nov. 3, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sanofi 9:00 a.m. Oct. 30, 2014 - PR Newswire - PRF
Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER 8:34 a.m. Oct. 28, 2014 - PR Newswire - PRF
New International GPCR Consortium Formed with Pharma and Academia to Advance Structural Information about G-protein Coupled Receptors 6:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
Sanofi Q3 2014 Results - Interview with Jérôme Contamine 3:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio 10:35 a.m. Oct. 20, 2014 - BusinessWire - BZX
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis 7:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy 8:01 a.m. Oct. 16, 2014 - GlobeNewswire
New Survey Finds Differences In Attitudes About Diabetes Based On Age 8:00 a.m. Oct. 15, 2014 - PR Newswire - PRF
Genzyme Announces Winners of Patient Advocacy Leadership (PAL) Awards 8:00 a.m. Oct. 1, 2014 - BusinessWire - BZX
Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 1:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Scanning Pharma Equities - Novo Nordisk, Teva Pharma Industries, Sanofi, Valeant Pharma Intl., and Eli Lilly 9:10 a.m. Sept. 26, 2014 - PR Newswire - PRF
Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness 8:00 a.m. Sept. 24, 2014 - BusinessWire - BZX
Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease 8:34 a.m. Sept. 17, 2014 - PR Newswire - PRF
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies 1:00 a.m. Sept. 11, 2014 - BusinessWire - BZX
Loading more headlines...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 147

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
Scalefusion’s Platinum Win Sharpens Its Brand Story

Updated Category News Views 14

A Film Is Not a Balance Sheet A slick brand film cannot patch a leaky product, but it can make a complicated platform easier to remember. That is the sensible takeaway from Scalefusion’s Platinum Level win at the 2026 MarCom Awards for “One Platform. One Agent. We are Scalefusion.” The recognition is for creative execution, not commercial performance, and anybody...

Continue Reading
Three Deal Reviews Put Merger Terms Under Scrutiny

Updated Category News Views 88

Three proposed transactions just picked up the sort of legal glare boards hate seeing. A shareholder-rights firm, Halper Sadeh, said on November 18, 2026 that it is investigating whether the deals involving Greenland Energy, Rapid Micro Biosystems and Aytu BioPharma may involve federal securities-law violations or breaches of fiduciary duty. That is an allegation worth...

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 194

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 80

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today

Updated Category News Views 97

A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...

Continue Reading
Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 165

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading

Top 5 Most Recently Viewed Articles

Foresight Autonomous Holdings Reports 2024 Financial Outcomes

Updated Category News Views 231

Financial Overview of Foresight Autonomous Holdings Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) has recently disclosed its financial results for the fourth quarter and overall year of 2024. The company, known for its groundbreaking 3D perception systems, reported annual revenues of $436,000. By the end of the year, it held $7.2 million in cash and equivalents,...

Continue Reading
Imperial Metals Showcases Remarkable First Quarter Growth

Updated Category News Views 156

Imperial Metals Demonstrates Strong Performance in First Quarter Imperial Metals Corporation (TSX:III) has revealed its financial results for the first quarter of 2025, showcasing remarkable growth in production and revenue. The company aims to maintain a trajectory of operational efficiency and profitability, continuing its commitment to sustainable mining practices. Key...

Continue Reading
MOBILion Systems Redefines Mass Spectrometry in Proteomics

Updated Category News Views 144

A New Era for Mass-Spectrometry-Based Proteomics In a groundbreaking achievement, MOBILion Systems has demonstrated a remarkable technical milestone, fundamentally changing mass-spectrometry-based proteomics. The company's proof-of-concept for high-resolution ion mobility (HRIM) showcases its innovative PAMAF mode, setting a new standard for efficient and effective...

Continue Reading
Celebrating Excellence: FASTSIGNS Honors Top Vendors for 2024

Updated Category News Views 316

FASTSIGNS International Celebrates Outstanding Vendors Grimco and Spicers Recognized for Exceptional Supplier Relationship FASTSIGNS®, a leading name in custom signs and visual solutions, recently honored Grimco as the U.S. Vendor of the Year and Spicers as the Canadian Vendor of the Year during the 2025 FASTSIGNS International Convention. The event took place in a...

Continue Reading
Insights into Central Government's 2026 Borrowing Plans

Updated Category News Views 116

Overview of the Central Government's Borrowing Strategy The update regarding the central government's borrowing strategy for 2026 has been officially released, providing crucial insights into the planned financial activities for the period. This detailed plan outlines essential objectives and anticipated actions that aim to enhance the overall stability of the economy....

Continue Reading